37 related articles for article (PubMed ID: 12438246)
1. Computational investigations of the binding mechanism of novel benzophenone imine inhibitors for the treatment of breast cancer.
Shtaiwi A; Adnan R; Khairuddean M; Khan SU
RSC Adv; 2019 Oct; 9(61):35401-35416. PubMed ID: 35541022
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids, Sex Hormones, and Immunity.
Bereshchenko O; Bruscoli S; Riccardi C
Front Immunol; 2018; 9():1332. PubMed ID: 29946321
[TBL] [Abstract][Full Text] [Related]
3. The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.
Petta I; Dejager L; Ballegeer M; Lievens S; Tavernier J; De Bosscher K; Libert C
Microbiol Mol Biol Rev; 2016 Jun; 80(2):495-522. PubMed ID: 27169854
[TBL] [Abstract][Full Text] [Related]
4. Silencing MED1 sensitizes breast cancer cells to pure anti-estrogen fulvestrant in vitro and in vivo.
Zhang L; Cui J; Leonard M; Nephew K; Li Y; Zhang X
PLoS One; 2013; 8(7):e70641. PubMed ID: 23936234
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinase C α Modulates Estrogen-Receptor-Dependent Transcription and Proliferation in Endometrial Cancer Cells.
Thorne AM; Jackson TA; Willis VC; Bradford AP
Obstet Gynecol Int; 2013; 2013():537479. PubMed ID: 23843797
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.
Badia E; Oliva J; Balaguer P; Cavaillès V
Curr Med Chem; 2007; 14(28):3035-45. PubMed ID: 18220739
[TBL] [Abstract][Full Text] [Related]
7. Transcription activation by estrogen and progesterone receptors.
Gronemeyer H
Annu Rev Genet; 1991; 25():89-123. PubMed ID: 1667464
[No Abstract] [Full Text] [Related]
8. Cardiovascular effects of estrogen: implications of the discovery of the estrogen receptor subtype beta.
Foegh ML; Ramwell PW
Curr Opin Nephrol Hypertens; 1998 Jan; 7(1):83-9. PubMed ID: 9442368
[TBL] [Abstract][Full Text] [Related]
9. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
10. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
[TBL] [Abstract][Full Text] [Related]
11. Involvement of HP1alpha protein in irreversible transcriptional inactivation by antiestrogens in breast cancer cells.
Oliva J; El Messaoudi S; Pellestor F; Fuentes M; Georget V; Balaguer P; Cavaillès V; Vignon F; Badia E
FEBS Lett; 2005 Aug; 579(20):4278-86. PubMed ID: 16051232
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo.
Liu XF; Bagchi MK
J Biol Chem; 2004 Apr; 279(15):15050-8. PubMed ID: 14722073
[TBL] [Abstract][Full Text] [Related]
14. An estrogen-responsive element-targeted histone deacetylase enzyme has an antiestrogen activity that differs from that of hydroxytamoxifen.
Demirpence E; Semlali A; Oliva J; Balaguer P; Badia E; Duchesne MJ; Nicolas JC; Pons M
Cancer Res; 2002 Nov; 62(22):6519-28. PubMed ID: 12438246
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
